c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse
- 31 December 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (10), 1600-1604
- https://doi.org/10.1016/0959-8049(92)90050-c
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Adjuvant Therapy of Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast TumorsJNCI Journal of the National Cancer Institute, 1988
- A human retinoic acid receptor which belongs to the family of nuclear receptorsNature, 1987
- Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancerBreast Cancer Research and Treatment, 1986
- Standardization of steroid receptor assays in human breast cancer—I. Reproducibility of estradiol and progesterone receptor assaysEuropean Journal of Cancer and Clinical Oncology, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958